This Always Works: So Far

 

 

October 23, 2011
Volume
XIII, Issue 101

Home Page : www.otcjournal.com

Email Questions or Comments To:
editor@otcjournal.com
 

To OTC Journal Members:

This Always Works: So Far

 

Well, so far it always works. It’s the stock market, so there’s no absolute guarantees. However, about 5 times a year I find a special situation that works for a number or reasons. I’ve found the third in the last year, and you’ll have the chance to learn about it on Tuesday.

In the past year I have only found two of these Special Situations. Here’s the record so far:

 

As you can see, my Special Situation recommendation on CEHD yielded at 73% return in 5 weeks, and my Special Situation report on CMCI yielded 45% in just 5 trading days.

These ideas are few and far between, and they are simply MONEY!!!

On Tuesday, you will receive a simple, plain text email from me with the details of my next Special Situation idea. Please look for it. You’ll have an opportunity to actually “hear” about the idea. Use it as you like.

Midas Medici (OTC BB: MMED): It’s Just a Question of Time

 

On Friday, after the market closed, my “sleeper” idea – Midas Medici (MMED)- the Brazilian IT company with well over $100 million in annual revenues and an absurd market cap of under $30 million, gave us more evidence on Friday to believe this stock is going to take off sooner or later.

On Friday after the market closed, MMED announced its CIMCORP subsidiary landed another nice contract. The military police of Sao Paulo, Brazil has awarded the company a $1.3 million contract to upgrade the military’s server infrastructure and virtualization.

At some point investors will blink, and this stock will be $10. It’s not if- it’s when.

Home Page : www.otcjournal.com

Email Questions or Comments To:

editor@otcjournal.com

 


 

Refer
A Friend

If you find the OTC Journal informative
and profitable, please forward our newsletter alert service to like-minded
friends and associates who share similar market interests.


Ensure
Newsletter Delivery

To ensure newsletter delivery, you
can add any additional email
addresses you may have to the OTC Journal Member List. Receiving the OTC
Journal Newsletter in multiple locations is the best way of making sure
you don’t miss the next investing or trading opportunity! For web based
email addresses, the OTC Journal recommends @yahoo.com or @aol.com for
timely and reliable email newsletter delivery.

Note: Your email address will
be kept strictly confidential, and will not be shared with any other entity
for any purpose at any time. If you no longer wish to receive the OTC Journal,
simply follow the instructions located at the bottom of every OTC Journal
Newsletter Edition.

 


 

 

Disclaimer
DISCLAIMER

The OTC Journal Newsletter is an
electronic publication committed to providing our readers with useful information
on publicly traded companies. The Newsletter contracts with publicly traded
companies and receives compensation from them in the form of cash and sometimes
restricted securities as payment for publishing information and opinion
about the company and the trading market for their securities. Principals
of the Newsletter may also purchase or sell securities of the companies
in the open market from time to time. The positions that the Newsletter
or its principals maintain in securities of the companies are disclosed
here (click
here
) and should be considered in making an investment decision regarding
these companies securities. The Newsletter may be deemed to have
a conflict of interest between its open market activity and positions in
these securities and the timing of and opinions expressed in its publications
concerning these companies. The publications should not be considered
to be independent publications concerning the company.

All statements and opinions expressed
herein are those of the editors and are subject to change without notice.
The Newsletter maintains editorial control over its publications and the
companies profiled therein do not have any editorial rights concerning
the information published about them. A profile, description, or other
mention of a company in the newsletter is neither an offer nor solicitation
of an offer to buy or sell any securities mentioned. While we believe all
sources of information provided by us and contained in our publication
to be accurate and reliable, we cannot and do not guarantee the accuracy
of information we received from third parties.

READERS ARE ENCOURAGED TO DO
THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN
THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A
HIGH DEGREE OF RISK.

We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission (“SEC”) at http://www.sec.gov
and/or the National Association of Securities Dealers (“NASD”) at http://www.finra.org.
We also recommend that you read the SEC advisory to investors concerning
Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC’s EDGAR page.
The NASD has published information on how to invest carefully at its web
site.

The information found in this profile
is protected by the copyright laws of the united states and may not be
copied, or reproduced in any way without the expressed, written consent
of the editors of otcjournal.com.

 

You can unsubscribe
from this list at any time by Clicking
Here
. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt/?email=$subst(‘Recip.EmailAddr’).

Comments are closed.